F2RL1 and ovarian carcinoma: This corresponds with data published by Jiang Yuhong et al. [28] showing high expression levels of PAR2 in ovarian cancer in a large patient population using several web server tools, such as the Cancer Genome Atlas (TCGA), Genotype-Tissue Expression (GTEx), and Gene Expression Omnibus (GEO) databases.